Beijing where treats pulmonary hypertension to be good?

Update Date: Source: Network

summary

Many people may be unfamiliar with pulmonary hypertension, but it is not rare and dangerous. It is generally less than 2.8 years from diagnosis to death, which is far lower than the survival rate of lung cancer. Now let's share about where to treat pulmonary hypertension in Beijing? The knowledge of.

Beijing where treats pulmonary hypertension to be good?

First, it is understood that pulmonary hypertension refers to the persistent increase of pulmonary artery pressure caused by various reasons. When it exceeds the normal maximum value, it is pulmonary hypertension. Because the patient's heart is suffering from severe hypoxia for a long time, his lips will appear dark purple. It is precisely because of this feature that patients with this disease are often referred to as "blue lips". Not only that, chest tightness, shortness of breath, dizziness and other symptoms make every step of the patient extremely difficult. A patient with pulmonary hypertension, 6 minutes walk 100 meters are very hard, poor quality of life.

Second, pulmonary hypertension has been considered as an incurable disease in clinic. In recent years, although life expectancy can be prolonged through drug remission, most families can't afford the annual cost of hundreds of thousands or even millions of drugs. Moreover, the therapeutic effect of drugs is limited and the side effects are large. Some patients failed to reduce the pressure, but produced severe anemia.

Third: under such circumstances, Chen Shaoliang, vice president of Nanjing First Hospital, led the cardiovascular department of the hospital to invent "percutaneous pulmonary denervation", which provides a new way for the treatment of some patients with pulmonary hypertension. The results immediately caused a sensation in the industry.

matters needing attention

Although the causes of pulmonary hypertension are complex, they are mostly related to the abnormal activation of sympathetic nerve. The "percutaneous pulmonary artery denervation" starts from the sympathetic nerve and relieves symptoms through operation. At present, more than 90 patients have benefited from it, including 2 patients from the United States, 3 patients from France and 5 patients from Russia.